Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas E Vaughan

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Circulation|July 30, 2003
Plasminogen activator inhibitor-1 and the calculus of mortality after myocardial infarctionDouglas E Vaughan
Transactions of the American Clinical and Climatological Association|June 21, 2011
PAI-1 antagonists: the promise and the perilDouglas E Vaughan
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
PAI-1 and cellular migration: dabbling in paradoxDouglas E Vaughan
Arteriosclerosis, Thrombosis, and Vascular Biology|March 25, 2006
PAI-1 and TGF-beta: unmasking the real driver of TGF-beta-induced vascular pathologyDouglas E Vaughan
American Journal of Hypertension|February 5, 2002
Angiotensin and vascular fibrinolytic balanceDouglas E Vaughan
The Journal of Clinical Investigation|September 15, 2023
Mouse model hints at pharmacogenomic strategies for stroke treatment in patients possessing a risk variantDouglas E Vaughan
Journal of Cellular Physiology|April 6, 2011
PAI-1 in tissue fibrosisAsish K Ghosh, Douglas E Vaughan
Journal of the American College of Cardiology|April 1, 2014
Going mobile: enhanced recovery from myocardial infarction via stem cell mobilization and homing for tissue repairDouglas W Losordo, Douglas E Vaughan
Journal of the American College of Cardiology|May 3, 2008
Clinical implications of the contrasting effects of in vivo thrombin receptor activation (protease-activated receptor type 1) on the human vasculatureJohn H Cleator, Douglas E Vaughan
Maturitas|May 3, 2011
Endothelial biology in the post-menopausal obese womanJudith L Meadows, Douglas E Vaughan
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Circulation|July 30, 2003
Plasminogen activator inhibitor-1 and the calculus of mortality after myocardial infarctionDouglas E Vaughan
Transactions of the American Clinical and Climatological Association|June 21, 2011
PAI-1 antagonists: the promise and the perilDouglas E Vaughan
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
PAI-1 and cellular migration: dabbling in paradoxDouglas E Vaughan
Arteriosclerosis, Thrombosis, and Vascular Biology|March 25, 2006
PAI-1 and TGF-beta: unmasking the real driver of TGF-beta-induced vascular pathologyDouglas E Vaughan
American Journal of Hypertension|February 5, 2002
Angiotensin and vascular fibrinolytic balanceDouglas E Vaughan
The Journal of Clinical Investigation|September 15, 2023
Mouse model hints at pharmacogenomic strategies for stroke treatment in patients possessing a risk variantDouglas E Vaughan
Journal of Cellular Physiology|April 6, 2011
PAI-1 in tissue fibrosisAsish K Ghosh, Douglas E Vaughan
Journal of the American College of Cardiology|April 1, 2014
Going mobile: enhanced recovery from myocardial infarction via stem cell mobilization and homing for tissue repairDouglas W Losordo, Douglas E Vaughan
Journal of the American College of Cardiology|May 3, 2008
Clinical implications of the contrasting effects of in vivo thrombin receptor activation (protease-activated receptor type 1) on the human vasculatureJohn H Cleator, Douglas E Vaughan
Maturitas|May 3, 2011
Endothelial biology in the post-menopausal obese womanJudith L Meadows, Douglas E Vaughan
Pageof 15